Dr Andrew Charlton is a Consultant Haematologist at the Northern Centre for Cancer Care where he has a particular interest in myeloma treatment, apheresis medicine and transfusion, and NHS Blood and Transplant.

 

Dr Charlton trained in the Northern Deanery as a Registrar and then worked at the Northern Centre for Cancer Care as a Clinical Fellow in the Haemato-Oncology Clinical Trials Team.

 

He has a strong interest in developing the clinical trials portfolio at the Trust and was awarded NIHR ‘Greenshoots’ funding. He is Clinical Lead for Transfusion and part of the Sub-Regional Immunoglobulin Assessment Panel. He is an examiner for the FRCPath examination.

Dr Andrew Charlton has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Advisory Board: Sanofi, Takeda

Consultancy: Menarini Stemline, BMS

Speaker’s Fees: JNJ, Takeda, Sanofi, Menarini Stemline, Pfizer

Conference Support: JNJ, Takeda, Amgen, BMS, Menarini Stemline